John C Thomas
CIK 1424620 · CFO and Secretary · last filed 2025-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$657.1K
Companies
7
Total Filings
42
Lifetime Open-Market Net
-$1.91M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DWTX | Director | — | $1.54 | — | $0 | 2 | 2025-07-01 |
| Dogwood Therapeutics, Inc. (VIRI) Delisted | Director | 1,000 | $3.88 | $3.9K | $5.7K | 5 | 2024-02-28 |
| ImmunityBio, Inc. (NK) Delisted | Director | 221,363 | — | — | -$1.92M | 19 | 2020-12-11 |
| NOVELION THERAPEUTICS INC. (NVLN) Delisted | Director | — | — | — | $0 | 2 | 2018-08-13 |
| Innoveren Scientific, Inc. (MDVXW) Delisted | Director | 109,960 | — | — | $0 | 2 | 2017-11-01 |
| QLTI | Director | 24,500 | $26.82 | $657.1K | $0 | 7 | 2016-06-21 |
| Midatech Pharma US Inc. (DARA) Delisted | CFO and Secretary | 325,609 | — | — | $0 | 3 | 2012-05-17 |
Recent Filings · Page 4 of 5
42 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-05-27 | ImmunityBio, Inc. (NK) Delisted | Exer (M) | +277,725 | $60.0K | EDGAR |
| 2016-03-08 | ImmunityBio, Inc. (NK) Delisted | Gift (G) | −18,511 | $0 | EDGAR |
| 2016-03-08 | ImmunityBio, Inc. (NK) Delisted | Gift (G) | −16,000 | $0 | EDGAR |
| 2015-07-01 | QLTI | Exer (M) | +25,000 | $87.1K | EDGAR |
| 2015-06-09 | QLTI | Exer (M) | +10,000 | $0 | EDGAR |
| 2014-12-19 | QLTI | Grant (A) | — | $0 | EDGAR |
| 2014-12-17 | QLTI | Exer (M) | +2,000 | $0 | EDGAR |
| 2013-07-17 | QLTI | Grant (A) | — | $0 | EDGAR |
| 2012-07-19 | QLTI | Grant (A) | — | $0 | EDGAR |
| 2012-05-17 | Midatech Pharma US Inc. (DARA) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.